Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
GTI Energy

Related Posts

Copper Quest Exploration

November 19, 2025

Rare Earths Market Forecast: Top Trends for Rare...

January 13, 2026

Nifty Copper Project Virtual Site Visit

June 19, 2025

Canadian Securities Exchange to Acquire National Stock Exchange...

May 22, 2025

Gold and Crypto: Redefining the Future of Finance

October 24, 2025

Early Warning News Release Regarding the Issuance of...

November 26, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (265)
    • Investing (1,855)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved